DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · Real-Time Price · USD
8.00
-0.04 (-0.50%)
Oct 16, 2026, 10:28 AM EDT - Market open
DiaMedica Therapeutics Employees
DiaMedica Therapeutics had 35 employees as of December 31, 2025. The number of employees increased by 7 or 25.00% compared to the previous year. That makes DiaMedica Therapeutics the 36,452nd largest employer in the world and 5,036th in the United States.
Employees
35
Change (1Y)
7
Growth (1Y)
25.00%
Revenue / Employee
n/a
Profits / Employee
-$1,072,600
Market Cap
431.41M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 35 | 7 | 25.00% | 35 | 0 |
| Dec 31, 2024 | 28 | 9 | 47.37% | 27 | 1 |
| Dec 31, 2023 | 19 | 3 | 18.75% | 18 | 1 |
| Dec 31, 2022 | 16 | 1 | 6.67% | 16 | 0 |
| Dec 31, 2021 | 15 | 4 | 36.36% | 14 | 1 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| MapLight Therapeutics | 133 |
| Assembly Biosciences | 73 |
| Prothena Corporation | 67 |
| AgomAb Therapeutics NV | 62 |
| Tectonic Therapeutic | 60 |
| Oculis Holding AG | 60 |
| Rezolute | 58 |
| Eupraxia Pharmaceuticals | 49 |
DMAC News
- 16 days ago - DiaMedica Therapeutics Announces Key Opinion Leader Webinar on DM199 for Fetal Growth Restriction Featuring Early Phase 2 FGR Results - Business Wire
- 6 weeks ago - DiaMedica Therapeutics to Participate in Upcoming September Investor Conferences - Business Wire
- 2 months ago - DiaMedica Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - DiaMedica Therapeutics Quarterly report: Q2 2026 - Filings
- 2 months ago - DiaMedica Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - DiaMedica Therapeutics reports Q2 EPS (19c), consensus (20c) - TheFly
- 2 months ago - DiaMedica Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Highlights - Business Wire
- 2 months ago - DiaMedica Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Business Update August 11, 2026 - Business Wire